IperionX valuation now hinges on Virginia converting prototypes into repeat orders

IperionX (ASX: IPX) now has its Virginia titanium manufacturing campus online, government funding largely locked in, and a free transfer of about 290 metric tons of titanium scrap to feed current operations.

That is the core tension in the stock today. The underlying asset base and strategic position look stronger than they did a year ago, but the business is still working through the hard, cyclical part of the story: proving it can ramp production, win repeat orders and turn technical promise into sustained revenue.

Over the last 12 months, the share price has been driven less by broad materials sentiment and more by a series of company-specific milestones.

The biggest shift came with the October 30 update confirming major manufacturing equipment was online in Virginia, powder capacity had lifted to 200 tonnes per annum, and expansion to 1,400 tonnes per annum was underway with commissioning targeted for mid-2027. That mattered because it marked the move from development story to commercial operator, even if only at an early scale.

What are the Best ASX Stocks to invest in right now?

Check our buy/sell tips

What the market may be missing

Since then, the stock has stayed in the market’s line of sight as smaller but important orders and certifications have followed. In our view, that pattern explains why investors are paying attention now: the company has crossed into commercial production, but it still needs evidence that demand and margins can follow.

IperionX is a titanium metal and critical materials company building an integrated mineral-to-metal business in the United States. In plain English, it wants to produce titanium from either scrap titanium or titanium minerals, and then make higher-value titanium products from that feedstock. That is different from a simple miner or a basic materials processor.

Its key operating asset today is the Titanium Manufacturing Campus in Halifax County, Virginia. That site is producing titanium powder and manufacturing titanium components and semi-finished products. End uses include high-performance titanium alloys, fasteners, tank track pins, consumer electronics enclosures, pump impellers and additive manufactured parts. Revenue today is tied to product sales, prototype orders and customer qualification work, particularly in defense and industrial applications.

The next catalyst is becoming clearer

Behind that sits a second layer of value: the Titan Project in Tennessee. Titan is still in exploration and study phase, with a Definitive Feasibility Study (DFS) due in Q2 2026.

If developed, it could provide domestic feedstock for titanium, zircon and potentially rare earth-related products. We think the market gives Titan some credit, but the current valuation is still anchored mainly to whether Virginia can scale into a real commercial business.

The largest share price reaction over the period appears tied to the October announcement that Virginia operations were online and expanding. That was the moment the market had been waiting for. A company talking about patented titanium technologies is one thing; a company with commissioned production equipment and an expansion pathway is another.

Subsequent announcements have reinforced that shift. On December 15, IperionX announced an initial order of about US$100,000 from Carver Pump to develop four prototype titanium pump impellers for a U.S.

Navy shipbuilding program days

Two days later, it announced ISO 9001 certification for the Virginia operations. For a retail investor, that certification may sound routine, but it matters because qualification hurdles are often the gatekeeper to procurement in defense, aerospace and industrial supply chains.

Then in January came two announcements that strengthened the investment case. On January 16, the final US$4.6m under the US$47.1m Industrial Base Analysis and Sustainment (IBAS) funding package was obligated, and the U.S.

Government transferred around 290 metric tons of titanium scrap at no cost. That equates to roughly 1.5 years of feedstock at current capacity. On January 22, IperionX announced a US$0.3m prototype order from American Rheinmetall for 700 lightweight titanium components for U.S. Army heavy ground combat systems.

These are not large revenue numbers in themselves. But we believe the market has treated them as validation events. They show IperionX is moving from laboratory-scale credibility to real-world customer testing.

What’s the driver for IPX valuation

The most important driver of IperionX’s valuation right now is not the Titan Project, and not even the size of its government support. It is whether the Virginia business can show repeatable commercial demand at economics that justify the scale-up to 1,400 tonnes per annum.

That is the pressure point. Titanium is attractive because of its performance characteristics, but it is not an easy market to crack. Qualification cycles are long, customers are conservative, and scaling specialty metal production can be messy. The company’s patented HAMR and HSPT technologies may offer lower energy use, lower cost and lower carbon emissions, but investors still need operating data and customer orders to back that up.

The distinction between structural progress and short-term news matters here. Structural progress over the past three to six months includes Virginia coming online, the expansion project moving ahead, ISO certification, and government support being fully obligated. Those are durable developments that improve the company’s strategic position.

What’s IPX Balance Sheet Situation 

Short-term events include the prototype orders from Carver Pump and American Rheinmetall. They are encouraging, but they remain early-stage. In our opinion, the mistake would be to treat prototype activity as if it already guarantees large production contracts.

The balance sheet helps. IperionX had US$65.8m in cash at December 31, 2025, which gives it room to keep ramping operations and progressing the Titan DFS. That lowers immediate funding pressure at the corporate level, though Titan itself would still require project finance if it moves toward development.

For the stock to strengthen further, a few technical conditions need to be met. First, the company needs to deliver the Carver Pump and American Rheinmetall prototypes on time and to specification.

Second, those prototype programs need to convert into larger commercial agreements. Third, management needs to show that customer qualification translates into recurring sales rather than one-off purchase orders. Fourth, the GenX continuous HAMR platform needs to hit validation milestones in 2026, because that would support the case for lower-cost scale.

The final call from here

The catalyst that could change the market’s view most is simple: conversion of today’s prototype and qualification work into repeat commercial orders from defense and industrial customers. If that arrives alongside a steady Virginia ramp, the story moves from interesting to investable at a much larger scale.